SCHEDULE 13G: Individual Investor Andreas Bovopoulos Discloses Significant 6.97% Stake in Cosmos Health Inc.
Beneficial Ownership Disclosure
Andreas Bovopoulos has filed a Schedule 13G, reporting beneficial ownership of 6.97% of Cosmos Health Inc.'s common stock as of December 31, 2024.
Summary
- Andreas D. Bovopoulos, an individual investor, has reported beneficial ownership of 1,880,772.98 shares of Cosmos Health Inc. Common Stock.
- This ownership represents 6.97% of the total outstanding shares of Cosmos Health Inc., based on 26,979,875 shares outstanding as of February 26, 2025.
- Mr. Bovopoulos holds sole voting power and sole dispositive power over all 1,880,772.98 shares.
- The filing is a Schedule 13G, indicating a passive investment stake, and was filed on March 6, 2025, for the event date of December 31, 2024.
- Cosmos Health Inc.'s principal executive offices are located at 5 AGIOU GEORGIOU, PILEA, THESSALONIKI, GREECE, 55438.
Sentiment
Score: 6
Explanation: The sentiment is mildly positive as it indicates a significant, passive investment by an individual, which can be seen as a vote of confidence. However, it provides no operational or financial performance details.
Positives
- The disclosure of a significant stake (6.97%) by an individual investor like Andreas D. Bovopoulos can be interpreted as a vote of confidence in Cosmos Health Inc.'s future prospects.
Future Outlook
NA
Industry Context
This filing is a standard disclosure of a significant passive ownership stake by an individual investor in a publicly traded company. It does not provide specific insights into broader industry trends or competitive landscape, but rather reflects an individual's investment position within the healthcare or pharmaceutical sector, where Cosmos Health Inc. operates.
Stakeholder Impact
- Shareholders: The disclosure of a significant individual stake may positively influence market perception and potentially share price, signaling investor confidence.
- Management: Awareness of a new significant shareholder may influence strategic considerations, though a passive 13G filing typically implies no immediate intent to influence control.
Key Dates
| Date | Description |
|---|---|
| 2024-12-31 | Date of event which required the filing of this statement (beneficial ownership threshold met). |
| 2025-02-26 | Date as of which the total outstanding shares (26,979,875) of Cosmos Health Inc. were reported for percentage calculation. |
| 2025-03-06 | Date the Schedule 13G statement was signed and filed. |
Keywords
Cosmos Health Inc., Andreas D Bovopoulos, Schedule 13G, Beneficial Ownership, Common Stock, Equity Stake, Investment, Shareholder, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.